Daily Mail | It's time we got moving to make cancer drugs affordable Daily Mail Herceptin was not patentable under Indian law since it was developed prior to 1995, so Roche filed for secondary patents on an Indian patent it had for a combination of HER2+ antibody with 'acidic variants'. This was challenged because it was just ... |
